Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

1H24 result: Giddy up

Percheron Therapeutics
3:27pm
February 29, 2024
PER has reported its 1H24 results. No surprises here given quarterly updates. Cash balance remains the major key metric, which is sufficient to fund PER until the Ph2b topline outcome at the end of the year. Focus remains solely on near-term catalysts including recruitment milestones, toxicology study, and Ph2b top-line results due to read out by the end of the year. No changes to our valuation which remains A$0.23 p/s. We view PER as having one of the best risk/return profiles in the space with clear near-term catalysts, strong board and management team, and scientific support for success.

Profitable growth expected for FY24

MedAdvisor
3:27pm
February 29, 2024
MDR reported its 1H24 result which was in line with pre-released update, with revenue up 18% and EBITDA up 21%. Management is guiding to profitability for FY24. The investment into the UK is completed and the transition to a SaaS platform is complete. In addition MDR will invest A$10m to A$15m to build out a shared service structure, looking to optimise a cloud native platform with the aim of reducing operating costs over time.

Approaching start of clinical trial

Tissue Repair
3:27pm
February 28, 2024
TRP posted its 1H24 result with a net loss of $2.3m, finishing the period with sufficient capital to fund its clinical program. TRP expects the Phase 3 trial for venous leg ulcers (VLU) to start recruiting in 1Q25 which is a slight delay from the last update (was 4Q24) and top-line results to be reported late CY25. The National Institute of Health estimates the cost of treating VLUs in the US at between US$2.5bn and US$3.5bn pa. The cosmetic gel product, TR Pro+, was successfully launched, with initial feedback positive. TRP will continue to drive increased awareness as well as explore potential partnership and distribution opportunities.

Offsetting the cycle with acquisitions

Peter Warren Automotive
3:27pm
February 28, 2024
PWR reported NPBT -20% on the pcp, with the core business (ex-acquisition) down ~30%. Heightened operating and funding costs dragged on the half. The order book closed flat over the half, however down ~25% from the July-23 acquisition position. Orders have remained solid and broadly in-line with deliveries. PWR expects continued revenue growth, however new car margins to ‘taper’. PWR’s ROS margin dropped to 2.9% in 1H24 and we expect further compression. PWR’s balance sheet remains in a position to continue to execute on its consolidation strategy. However, the cyclical margin and structural cost impacts have been clear in this result and we expect earnings to continue to decline. Whilst we view PWR as relatively cheap (on 9x PE), we expect it will be difficult to re-rate against the negative earnings trajectory. We move to Hold.

Heading in the right direction

Flight Centre Travel
3:27pm
February 28, 2024
FLT’s headline result was stronger than we expected. Adjusting for items which are now reported below the line, the result was just below our forecast but was materially below consensus given it underestimated FLT’s seasonal earnings skew. Importantly, the core business units (Corporate and Leisure) both beat our forecast and their margins are scaling nicely. FLT is well on track to deliver its FY24 guidance. We have made double digit upgrades to our NPBT forecasts given the non-cash amortisation on the convertible notes (CN) will be reported below the line (like WEB) and it has paid off ~A$250m debt and bought back A$84m of CN. For these reasons and given FLT’s margins will continue to improve, we now have more confidence in it achieving its 2% margin target. We assume this is achieved in FY26 vs FLT’s aim of FY25. We think today’s share price weakness is overdone and represents a great buying opportunity. Trading on an FY25 PE of 13.3x, we reiterate our Add rating.

Building on its strong market ties

Woodside Energy
3:27pm
February 28, 2024
A strong CY23, with underlying EBITDA/NPAT ahead of consensus by +1%/+9%. An equally strong final dividend of US60 cents (vs VA/MorgansF US/40 cents). This was supported by the recent news that WDS had agreed to sell down a 15% stake in the Scarborough field to JERA, with a Heads of Agreement for 0.4mtpa of LNG. Analyst roundtable focused on modelling and understanding the Scarborough deal. We maintain an Add rating, with a A$34.20 target price (was A$34.30).

1H24 result: Focusing on integration

Avada Group
3:27pm
February 28, 2024
In 1H24 AVD delivered LFL revenue and EBITDA growth of 4% and 6%, respectively. Group underlying NPATA was up 19.3% to A$3.2m. Margins held steady hoh (GM +60bps; EBITDA -60bps) and were up strongly on the pcp (GM +300bps; EBITDA margin +130bps). Integration of recent acquisitions (STA and Wilsons); cost control; operational efficiencies; and delivery of a strong pipeline of projects remains the focus. AVD’s FY24 underlying EBITDA guidance of A$20-22m (excluding STA) was last reaffirmed at its AGM (Nov-23). Annualised 1H24 group EBITDA is currently running at ~A$18.5m. AVD intends to declare a FY24 full year dividend (subject to maintaining current trajectory and cash flow conversion).

Executing well on the controllables

Kina Securities
3:27pm
February 28, 2024
KSL’s FY23 Net Profit Before Tax (PGK 175m) was +18% on the pcp and +3.5% above MorgansE. KSL’s FY23 underlying NPAT (PGK105m) was in-line with the pcp (impacted by the lift in the tax rate on PNG banks to 45% from 30%), and ~+10% above MorgansE This was broadly a good result by KSL, in our view.  Management delivered ~+20% underlying PBT growth in a more difficult net interest margin environment, with costs and bad debts being well contained. We lift our KSL FY24F/FY25F EPS forecasts by ~4%-7% on higher non-interest income and reduced cost estimates. Our target price rises to A$1.24 (previously A$1.14). KSL continues to deliver solid underlying profit growth, and trading on ~5x FY24F EPS and a >10% dividend yield, we see the stock as too cheap. ADD. We lift our KSL FY24F/FY25F EPS forecasts by ~4%-7% on higher non-interest income and reduced cost estimates. Our target price rises to A$1.24 (previously A$1.14).

Shifting gears for the new route ahead

Motorcycle Holdings
3:27pm
February 28, 2024
MTO delivered 1H24 EBITDA (pre-AASB) of A$14.2m (guidance A$14-16m); and NPAT of A$6.6m (-37% on the pcp; and -47% hoh; and -6% vs MorgansF). LFL comps vs pcp: sales -7%; GP -11%; Opex -2%; EBITDA (post-AASB) -30%; and Underlying EBITDA (pre-AASB) -%. Encouragingly, MTO pointed to improving trade through Jan-Feb; continued to grow its market share of new motorcycles (~15% in 1H24); expand its product range (CFMOTO); and will benefit from a seasonally stronger 2H within Mojo. We recently moved to a Hold recommendation given limited earnings visibility and lower confidence in the near-term outlook. While we expect improved operating performance in 2H24, we prefer to wait for greater evidence of earnings certainty before considering a more positive view.

NIM rebases as the loan book rebalances

MoneyMe
3:27pm
February 28, 2024
MoneyMe’s (MME) 1H24 result was largely per expectations as key headline operating metrics were pre-released. Total revenue of A$108m (-~11% on pcp) was achieved on a gross loan book of ~A$1.2bn (flat on the sequential half). The key positive in the result, in our view, was the continued uptick of asset quality of the book, with MME focusing on originating higher credit quality loans in recent periods. Our FY24F-FY26F EBITDA is altered by ~-19%-+6% on adjustments to our book yield estimates as secured assets become a higher proportion of the gross loan book as well as some changes to our operating costs assumptions. Our DCF/PB blended valuation (equal-weighted) and price target is lowered marginally to A$0.23 (from A$0.25) on the above changes and a valuation roll-forward. We maintain our Speculative Buy recommendation.

News & Insights

In recent weeks, there has been much discussion about the inflationary effect of Trump tariffs. Our Chief Economist, Michael Knox shares his views.

In recent weeks, there has been much discussion about the inflationary effect of Trump tariffs. This is sparked by Donald J. Trump's proposal of a 10% revenue tariff. Interestingly, the idea of a 10% revenue tariff was first discussed during his first term. At that time, it was considered as a potential source of additional revenue to offset the Trump tax cuts enacted during his first term.

The challenge in passing finance bills in the U.S. lies in the legislative process. Finance bills can only be easily passed if they are reconciliation bills, meaning they have no effect on the budget balance. When a finance bill does not affect the budget balance, it requires only a simple majority in the U.S. Senate to pass. However, when a finance bill increases the budget deficit, it requires at least 60-votes in the Senate, making such bills much harder to pass.

During Trump's first term, the administration found that by reducing certain tax write offs or tax cuts for specific states, they could pass the overall tax bill without effecting the budget balance. This allowed significant tax cuts for individuals and a major corporate tax cut, reducing the U.S. corporate tax rate from 35% to 21%. Now, as Trump seeks to cut corporate taxes again—this time from 21% to 15%, matching the German corporate tax rate—he needs additional revenue to balance the bill. This is so he can pass it as a reconciliation bill, requiring only 51 Senate votes. This has led to renewed discussions about the 10% revenue tariff.

In contrast to the European Union, where a value-added tax (VAT) would be a straightforward solution, implementing a VAT in the U.S. is effectively impossible due to constitutional constraints. A VAT would require unanimous agreement from all states. This is impossible in practise. So, the idea of a 10% revenue tariff has resurfaced.

Critics, particularly within the Democratic Party, have argued that such a tariff would be highly inflationary. However, when questioned during confirmation hearings, Trump's Treasury secretary nominee, Scott Bessent, referencing optimal tariff theory, explained that a 10% revenue tariff would increase the U.S. dollar exchange rate by 4%. We note that this would result in a maximum inflationary effect of 6% only if 100% of domestic goods were imported. Given that only 13% of domestic goods are imported, the actual inflationary impact would be just 0.8% on the Consumer Price Index (CPI). This makes the tariff effectively inflation neutral.

This idea was discussed by a panel of distinguished economists at the American Economic Association Convention in January, including Jason Furman, Christy Romer, Ben Bernanke, and John Cochrane. Cochrane noted that historical instances of tariff increases, such as in the 1890s and 1930s, did not lead to inflation because monetary policy was tight. He argued that the inflationary impact of tariffs depends entirely on the Federal Reserve's monetary policy. If the Fed maintains a firm stance, there would be no inflationary effect.

Trump's current plan is to pass a comprehensive bill that includes the Reciprocal Trade Act, corporate tax cuts, and the 10% revenue tariff. Peter Navarro, in a CNBC interview on 21 January, estimated that the revenue tariff could generate between $US350and$US400 billion, offsetting the cost of the tax cuts and making the bill feasible as a reconciliation measure.

With the Republican Party holding enough Senate seats, the legislation could pass by the end of April. The inflationary impact of the tariff, estimated at 0.8%, can be easily managed through moderately tight monetary policy by the Federal Reserve.


Morgans clients receive access to detailed market analysis and insights, provided by our award-winning research team. Begin your journey with Morgans today to view the exclusive coverage.

      
Contact Us
      
Read more
Michael Knox discusses the challenges the Reserve Bank of Australia (RBA) faces in cutting rates. He explores a model of Australian short-term interest rates, and how its components interact.

Today, I want to discuss the challenges the Reserve Bank of Australia (RBA) faces in cutting rates. To do this, I’ll explore our model of Australian short-term interest rates, and how its components interact. A key focus will be the relationship between inflation and unemployment, and how this relationship makes it particularly difficult for the RBA to now lower rates.

Our model of the Australian cash rate is robust, explaining just under 90% of the monthly variation in the cash rate since the 1990s, when the cash rate was first introduced. The model’s components include core inflation (not headline inflation), unemployment, and inflation expectations.

Interestingly, statistical tests show that unemployment is even more important than inflation when it comes to predicting what the RBA will do with the cash rate. This is because of the strong, leading relationship between Australian unemployment and core inflation.

To illustrate this, I’ve used data from the past ten years up until December, which shows the relationship between unemployment and inflation in Australia. The data reveals a Phillips curve, where inflation tends to fall as unemployment rises. This relationship begins to work appears almost immediately, though there is a slight delay of about 3 to 4 months before its full effect is felt.

We look at the data from 2014 to the end of 2024. When unemployment is around 4%—which is where it has been for the past few months—we can predict that core inflation should be around 3.7%. Currently, core inflation is 3.5%, which aligns closely with what we would expect given the unemployment rate. This suggests that the current level of inflation is consistent with current unemployment levels.

Unemployment vs Inflation

2014 to 2024

However, the RBA’s target inflation rate is between 2 and 3%, with a specific target of 2.5%. To achieve this target, unemployment would need to rise from its current level of 4% to around 4.6% or 4.7%. Historical data, such as from 2021, shows that with an unemployment rate of around 4.6%, inflation can be brought down to 2.5%. Therefore, to reduce inflation to the RBA’s target, the unemployment rate would need to increase slightly—though not drastically. If unemployment were allowed to rise to around 4.6%, it would create enough excess capacity in the economy to put downward pressure on inflation, which would take about 3 to 4 months to materialise.

If the RBA were able to allow this rise in unemployment, inflation would decrease to around 2.5%, and the RBA could cut rates. Current rates are at 4.35%, and under this scenario, we could expect them to drop to the low 3.0% range perhaps even lower. This would represent a fall of around 100 basis points from current levels.

Unfortunately, the situation is complicated by fiscal policy. The current Treasurer, Jim Chalmers, has been expanding employment in sectors like the National Disability Insurance Scheme (NDIS) and other areas of the public service. This fiscal stimulus is preventing unemployment from rising to the level needed for inflation to fall. As a result, unemployment remains stuck at around 4%, and inflation remains too high for the RBA to cut rates.

In terms of job vacancies and other labour market indicators, we would have expected unemployment to rise higher by now. However, Treasurer Chalmers is committed to keeping unemployment low ahead of the election, which is why we find ourselves in this position.

The government’s fiscal policy, aimed at maintaining a low unemployment rate, is preventing the necessary adjustment to bring inflation down.

If I input the current levels of inflation, unemployment, and inflation expectations into our model, the estimated cash rate should be 4.45%. This is 10 basis points higher than the current cash rate of 4.35%.

The Australian Government seems intent on maintaining the unemployment rate at 4% ahead of the election. If it does so, Inflation will remain too high for the RBA to cut rates.

Read more
The federal government has recommended a number of changes to the cost of residential aged care, which will commence from the beginning of 2025. Read more about the main measures to be introduced.

Following the release of the Aged Care Taskforce report earlier this year, the federal government has recommended a number of changes to the cost of residential aged care, some will commence from the beginning of 2025 and the remainder expected to commence from 1 July 2025.

Over the next 40 years, the number of people over 65 is expected to at least double and the number of people over 85 expected to triple. A significant amount needs to be invested in the Aged Care sector, by both government and private sector, to be able to manage the growing numbers of older people needing care and support in their later years.

From 1 January 2025:

  • Increasing the refundable accommodation deposit (RAD) maximum amount without approval from $550,000 to $750,000. This amount will be indexed annually.

From 1 July 2025:

  • Introduce a RAD retention amount of 2% pa to a maximum of 10% over 5 years.
  • Removing the annual fee caps and increasing the lifetime fee caps to $130,000 or 4 years, whichever occurs first.
  • Introducing a means-tested hotelling supplement of $12.55 per day which is to be indexed.
  • Removing the means tested fee and replacing it with a means tested non-clinical care contribution (NCCC). The daily maximum is $101.16 which is to be indexed.

From 2029/30:

  • The government is looking to commence a phase out RAD altogether by 2035. A commission will be established to independently review the sector in readiness.

Grandfathering arrangements will protect anyone who enters care prior to 1 July 2025 under the “no worse off” principle to ensure they do not pay more for their care.

Comparison of current and new aged care costs

Current aged care fees

The Basic Daily fee continues to be paid by all residents without change.

The Hotelling Supplement is paid by residents as a contribution towards their living costs. It is a means tested payment calculated at 7.8% of assets greater than $238k or 50% of income over $95,400 (or a combination of both). The Hotelling Supplement is capped at $12.55 per day (indexed).

The Non-Clinical Care Contribution (NCCC) replaces the current means tested fee. The NCCC is a contribution towards the cost of non-clinical care services which will be capped at $101.16 per day (indexed). It is a means tested fee calculated at 7.8% of assets over $501,981 or 50% of income over $131,279 (or a combination of both).

The lifetime cap for the NCCC is increasing to $130,000 or 4 years, whichever occurs first, indexed twice per year. There is no longer an annual cap.

Any contributions made under the home support program prior to entering residential aged care will count towards the NCCC cap.

Who will likely pay more from 1 July 2025?

It is expected that at least 50% of people entering care will pay more for their care each year.

The below chart illustrates the expected changes for regular care costs (excluding accommodation costs and retention amounts) for individuals based on specific asset levels:

Should you enter residential aged care before 1 July 2025?

It depends. For some people, if they have an ACAT assessment and are eligible to enter residential aged care, then it would be best to seek advice from your Morgans Adviser on both the current and future cost as well as cash flow and cost funding advice.


Contact your Morgans adviser today to schedule an aged care advice appointment. Our expert team will be able to simplify the aged care system, guide you through Government subsidies, analyse payment options, create 5-year cash flow projections, and model the benefits of home concessions and future asset values for your beneficiaries.

      
Contact Us
      
Read more